IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma

BACKGROUND: New biomarkers are needed to detect hepatocellular carcinoma at an earlier stage and to individualize treatment strategies. IL-6 has been proven to be associated with liver cancer in numerous studies. AIM: To evaluate the value of the IL-6 promoter methylation level as a noninvasive biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jie-Ru, Wang, Ju, Li, Hai-Ming, Gao, Shuai, Fan, Yu-Chen, Wang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962649/
https://www.ncbi.nlm.nih.gov/pubmed/35359408
http://dx.doi.org/10.3389/fonc.2022.746643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962649/
https://www.ncbi.nlm.nih.gov/pubmed/35359408
http://dx.doi.org/10.3389/fonc.2022.746643

Ejemplares similares